The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. - PubMed - NCBI

The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. - PubMed - NCBI

Genet Med. 2016 Sep 22. doi: 10.1038/gim.2016.143. [Epub ahead of print]

The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort.

Walker CE1, Mahede T1, Davis G2, Miller LJ3, Girschik J3, Brameld K4, Sun W3, Rath A5, Aymé S5, Zubrick SR6,7, Baynam GS1,7,8,9,10,11, Molster C1,Dawkins HJ1,4,12,13, Weeramanthri TS14.

Author information

Abstract

PURPOSE:

It has been argued that rare diseases should be recognized as a public health priority. However, there is a shortage of epidemiological data describing the true burden of rare diseases. This study investigated hospital service use to provide a better understanding of the collective health and economic impacts of rare diseases.

METHODS:

Novel methodology was developed using a carefully constructed set of diagnostic codes, a selection of rare disease cohorts from hospital administrative data, and advanced data-linkage technologies. Outcomes included health-service use and hospital admission costs.

RESULTS:

In 2010, cohort members who were alive represented approximately 2.0% of the Western Australian population. The cohort accounted for 4.6% of people discharged from hospital and 9.9% of hospital discharges, and it had a greater average length of stay than the general population. The total cost of hospital discharges for the cohort represented 10.5% of 2010 state inpatient hospital costs.

CONCLUSIONS:

This population-based cohort study provides strong new evidence of a marked disparity between the proportion of the population with rare diseases and their combined health-system costs. The methodology will inform future rare-disease studies, and the evidence will guide government strategies for managing the service needs of people living with rare diseases.Genet Med advance online publication 22 September 2016Genetics in Medicine (2016); doi:10.1038/gim.2016.143.

PMID:

 

27657686

 

DOI:

 

10.1038/gim.2016.143

[PubMed - as supplied by publisher]

Public Health Genomics Knowledge Base (v1.2)

RARE DISEASES

Last Updated: Sep 28, 2016

• The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort.
  Walker Caroline E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Sep
• The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort
  CE Walker et al, Genetics in Medicine, September 22, 2016
• Genetic variation: ExAC boosts clinical variant interpretation in rare diseases.
  Bahcall Orli G, et al. Nature reviews. Genetics 2016 9 (10) 584
• Let the Individuals Directly Concerned Decide: A Solution to Tragic Choices in Genetic Risk Information.
  Oliveri Serena et al. Public health genomics 2016 Sep 19(5)
• Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C.
  Koens L H, et al. Orphanet journal of rare diseases 2016 0 (1) 121
• Medical disorders: Stop marginalizing rare syndromes
  SO Kolset, Nature, August 2016
• Improving diagnosis of inherited peripheral neuropathies through gene panel analysis.
  Laššuthová Petra, et al. Orphanet journal of rare diseases 2016 0 (1) 118
• Collaborative Crowdsourcing for the Diagnosis of Rare Genetic Syndromes: The DYSCERNE Experience.
  Douzgou Sofia et al. Public health genomics 2016 19(1) 19-24
• Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases
  Kelly D. Farwell Hagman et al, Genetics in Medicine, August 11, 2016
• Ultra-rare Disease and Genomics-Driven Precision Medicine.
  Lee Sangmoon et al. Genomics & informatics 2016 Jun (2) 42-5
• Mom of first person saved by DNA sequencing fighting to increase access
  M Carstensen, Fix News, August 3, 2016
• Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
  Mariani Louise-Laure et al. JAMA neurology 2016 Jul
• Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates.
  Al-Shamsi Aisha et al. Orphanet journal of rare diseases 2016 11(1) 94
• MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients.
  Fiorillo C, et al. Orphanet journal of rare diseases 2016 0 (1) 91
• The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice.
  Nguyen M T et al. Clinical genetics 2015 Oct 88(4) 313-9

• CDC Information (1)
• CDC-Authored Pub (6)

• Human (25)
• Pathogen (0)

• Human (103)
• Pathogen (0)

• Human (27)
• Pathogen (0)

• Guidelines (4)
• Tier Table (0)
• Synthesis (5)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB